Corrigendum to The impact of risk factors on aspirin's efficacy for the prevention of preterm birth. American Journal of Obstetrics & Gynecology MFM. Volume 5, Issue 10, October 2023, 101095
| Errataetall: |
ErratumFor: Am J Obstet Gynecol MFM. 2023 Oct;5(10):101095. - PMID 37574046 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
American journal of obstetrics & gynecology MFM - (2024) vom: 22. Feb., Seite 101309 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 27.03.2024 published: Print-Electronic ErratumFor: Am J Obstet Gynecol MFM. 2023 Oct;5(10):101095. - PMID 37574046 Citation Status Publisher |
|---|
| doi: |
10.1016/j.ajogmf.2024.101309 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368856119 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368856119 | ||
| 003 | DE-627 | ||
| 005 | 20240327235911.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajogmf.2024.101309 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1351.xml |
| 035 | |a (DE-627)NLM368856119 | ||
| 035 | |a (NLM)38395633 | ||
| 035 | |a (PII)S2589-9333(24)00035-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nuss, Emily E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Corrigendum to The impact of risk factors on aspirin's efficacy for the prevention of preterm birth. American Journal of Obstetrics & Gynecology MFM. Volume 5, Issue 10, October 2023, 101095 |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 27.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumFor: Am J Obstet Gynecol MFM. 2023 Oct;5(10):101095. - PMID 37574046 | ||
| 500 | |a Citation Status Publisher | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Hoffman, Matthew K |e verfasserin |4 aut | |
| 700 | 1 | |a Goudar, Shivaprasad S |e verfasserin |4 aut | |
| 700 | 1 | |a Kavi, Avinash |e verfasserin |4 aut | |
| 700 | 1 | |a Metgud, Mrityunjay |e verfasserin |4 aut | |
| 700 | 1 | |a Somannavar, Manjunath |e verfasserin |4 aut | |
| 700 | 1 | |a Okitawutshu, Jean |e verfasserin |4 aut | |
| 700 | 1 | |a Lokangaka, Adrien |e verfasserin |4 aut | |
| 700 | 1 | |a Tshefu, Antoinette |e verfasserin |4 aut | |
| 700 | 1 | |a Bauserman, Melissa |e verfasserin |4 aut | |
| 700 | 1 | |a Tembo, Abigail Mwapule |e verfasserin |4 aut | |
| 700 | 1 | |a Chomba, Elwyn |e verfasserin |4 aut | |
| 700 | 1 | |a Carlo, Waldemar A |e verfasserin |4 aut | |
| 700 | 1 | |a Figueroa, Lester |e verfasserin |4 aut | |
| 700 | 1 | |a Krebs, Nancy F |e verfasserin |4 aut | |
| 700 | 1 | |a Jessani, Saleem |e verfasserin |4 aut | |
| 700 | 1 | |a Saleem, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Goldenberg, Robert L |e verfasserin |4 aut | |
| 700 | 1 | |a Kurhe, Kunal |e verfasserin |4 aut | |
| 700 | 1 | |a Das, Prabir |e verfasserin |4 aut | |
| 700 | 1 | |a Hibberd, Patricia L |e verfasserin |4 aut | |
| 700 | 1 | |a Achieng, Emmah |e verfasserin |4 aut | |
| 700 | 1 | |a Nyongesa, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Esamai, Fabian |e verfasserin |4 aut | |
| 700 | 1 | |a Liechty, Edward A |e verfasserin |4 aut | |
| 700 | 1 | |a Bucher, Sherri |e verfasserin |4 aut | |
| 700 | 1 | |a Goco, Norman |e verfasserin |4 aut | |
| 700 | 1 | |a Hemingway-Foday, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Moore, Janet |e verfasserin |4 aut | |
| 700 | 1 | |a McClure, Elizabeth M |e verfasserin |4 aut | |
| 700 | 1 | |a Silver, Robert M |e verfasserin |4 aut | |
| 700 | 1 | |a Derman, Richard J |e verfasserin |4 aut | |
| 700 | 1 | |a Patel, Archana |e verfasserin |4 aut | |
| 700 | 0 | |a Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas Study Group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of obstetrics & gynecology MFM |d 2019 |g (2024) vom: 22. Feb., Seite 101309 |w (DE-627)NLM297893440 |x 2589-9333 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:22 |g month:02 |g pages:101309 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ajogmf.2024.101309 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 22 |c 02 |h 101309 | ||